We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$9.72B
AUM Growth
+$589M
Cap. Flow
-$37.2M
Cap. Flow %
-0.38%
Top 10 Hldgs %
31.39%
Holding
419
New
23
Increased
181
Reduced
152
Closed
9

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$48.3M
2
ABBV icon
AbbVie
ABBV
+$40.8M
3
SRE icon
Sempra
SRE
+$23.4M
4
CVX icon
Chevron
CVX
+$21.9M
5
HPQ icon
HP
HPQ
+$21.2M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$72M
2
ENB icon
Enbridge
ENB
+$61.3M
3
MSFT icon
Microsoft
MSFT
+$45.4M
4
KMB icon
Kimberly-Clark
KMB
+$42.1M
5
VIRT icon
Virtu Financial
VIRT
+$10.4M

Sector Composition

Rank Sector Weight
1 Technology 17.92%
2 Healthcare 16.37%
3 Financials 13.94%
4 Industrials 11.5%
5 Consumer Staples 11.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JCI icon
326
Johnson Controls International
JCI
$88.6B
$498K 0.01%
13,070
-150
-1% -$5.86K
FDN icon
327
First Trust Dow Jones Internet Index Fund ETF
FDN
$5.3B
$491K 0.01%
4,470
+1,590
+55% +$171K
HRL icon
328
Hormel Foods
HRL
$13.9B
$491K 0.01%
13,500
+1,500
+13% +$50.4K
VB icon
329
Vanguard Morningstar Small-Cap ETF
VB
$80.5B
$488K 0.01%
3,305
-40
-1% -$5.79K
BIP icon
330
Brookfield Infrastructure Partners
BIP
$18.9B
$477K ﹤0.01%
17,892
COP icon
331
ConocoPhillips
COP
$144B
$466K ﹤0.01%
8,492
+1,205
+17% +$62K
VIG icon
332
Vanguard Dividend Appreciation ETF
VIG
$112B
$455K ﹤0.01%
4,463
-240
-5% -$23.6K
TSM icon
333
TSMC
TSM
$2.08T
$452K ﹤0.01%
11,379
+64
+0.6% +$2.59K
AVY icon
334
Avery Dennison
AVY
$13.2B
$448K ﹤0.01%
3,900
FIS icon
335
Fidelity National Information Services
FIS
$23.5B
$447K ﹤0.01%
4,754
+231
+5% +$21.7K
ATVI
336
DELISTED
Activision Blizzard
ATVI
$443K ﹤0.01%
6,995
BNS icon
337
Scotiabank
BNS
$108B
$439K ﹤0.01%
6,800
COR icon
338
Cencora
COR
$60.5B
$437K ﹤0.01%
4,760
-150
-3% -$12.4K
MCO icon
339
Moody's
MCO
$84.3B
$437K ﹤0.01%
2,960
VMC icon
340
Vulcan Materials
VMC
$36B
$434K ﹤0.01%
3,377
AMJ
341
DELISTED
JP Morgan Alerian MLP Index ETN 5/24/24
AMJ
$412K ﹤0.01%
15,000
DSI icon
342
iShares MSCI KLD 400 Social ETF
DSI
$5.4B
$404K ﹤0.01%
+8,230
New +$395K
HPE icon
343
Hewlett Packard
HPE
$63.1B
$403K ﹤0.01%
28,069
-250
-0.9% -$3.55K
KSU
344
DELISTED
Kansas City Southern
KSU
$397K ﹤0.01%
+3,777
New +$403K
MPC icon
345
Marathon Petroleum
MPC
$92B
$390K ﹤0.01%
5,917
AET
346
DELISTED
Aetna Inc
AET
$385K ﹤0.01%
2,134
-300
-12% -$51.5K
CFR icon
347
Cullen/Frost Bankers
CFR
$10.4B
$379K ﹤0.01%
+4,000
New +$385K
MON
348
DELISTED
Monsanto Co
MON
$376K ﹤0.01%
3,219
+86
+3% +$10.2K
VBK icon
349
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.4B
$374K ﹤0.01%
2,325
IWP icon
350
iShares Russell Mid-Cap Growth ETF
IWP
$20B
$369K ﹤0.01%
6,124

Similar funds

Bahl & Gaynor's Q4 2017 Portfolio in Review

As of Q4 2017, Bahl & Gaynor held 419 positions worth $9.72B, up 6.4% from $9.13B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor's Q4 2017 filing shows 23 new, 181 increased, 152 reduced and 9 closed positions. Its largest new stake was iShares Core High Dividend ETF: 534,010 shares worth $9.63M. The largest sale was Merck, an estimated $72M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q4 2017 buy was iShares Core High Dividend ETF: 534,010 shares worth $9.63M.
  • Bahl & Gaynor added most to Amgen in Q4 2017, an estimated $48.3M increase.
  • Bahl & Gaynor's biggest Q4 2017 reduction was Merck, cutting an estimated $72M.
  • Bahl & Gaynor fully exited Virtu Financial in Q4 2017, selling an estimated $10.4M.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $9.72B portfolio in Q4 2017.
  • Bahl & Gaynor opened 23 new positions and closed 9 in Q4 2017.
  • Bahl & Gaynor's portfolio value rose 6.4% quarter-over-quarter to $9.72B.

Based on Bahl & Gaynor's 13F filing for Q4 2017, filed 13 Feb 2018.